학술논문
Budget impact of introducing subcutaneous vedolizumab as a maintenance therapy in biologic-naïve and biologic-experienced patients with ulcerative colitis in France
Document Type
Article
Author
Source
In: Expert Review of Pharmacoeconomics and Outcomes Research . (Expert Review of Pharmacoeconomics and Outcomes Research, 2023, 23(2):205-213)
Subject
Language
English
ISSN
17448379
14737167
14737167